CAS No. |
1292804-07-9 |
|---|---|
中文名称 |
拉替拉韦钠 |
英文名称 |
Raltegravir sodium |
别名 |
UTMQTKRZYSZBPI-UHFFFAOYSA-N;Raltegravir sodium |
标准英文名 |
sodium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate |
分子式 |
C20H20FN6NaO5 |
分子量 |
466.40 |
精确分子量 |
466.14 |
SMILES |
[O-]C1=C(C(NCC2=CC=C(F)C=C2)=O)N=C(C(C)(NC(C3=NN=C(C)O3)=O)C)N(C)C1=O.[Na+] |
标准SMILES |
[Na+].CC1=NN=C(O1)C(=O)NC(C)(C)C1=NC(=C([O-])C(=O)N1C)C(=O)NCC1C=CC(F)=CC=1 |
用途 |
Raltegravir sodium is a potent, orally active inhibitor of HIV integrase (IN), used for the treatment of HIV infection. |
InChIKey |
QLBNDXLKPYXCIW-UHFFFAOYSA-M |
|
|
评论 |
|---|